A round-up of new facility developments in the pharma sector, including updates from Novo Nordisk, Sagent, Penn Pharma, Vertellus and …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

